Our research team develops nanotechnology tools to better understand cardiometabolic diseases such as atherosclerosis, type 2 diabetes and obesity. We engineer, make and test new imaging probes, drug delivery vehicles and sensors that help to diagnose and treat these conditions. In addition to imaging and drug delivery projects, our laboratory investigates lipoproteins and their function and metabolic biology of immune cells. We also have long-standing interest in toxicology of synthetic and environmental nano-/microparticles and their effects on cardiometabolic health.
Advanced Drug Delivery Reviews
2015 - 2016(a year)
Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein
Ganesan Wewers L
S Rajaram M
The Journal of Immunology at Health Sciences & Human Services Library on August (2016) 23
Scavenger receptor B1, the HDL receptor, is expressed abundantly in liver sinusoidal endothelial cells